BioCentury | Jan 20, 2021
Finance

IPO queue bulges further as Adagene, NexImmune are among latest to file

...largest shareholder.Filing for smaller offerings this week were two companies developing therapies for aging disorders: Longeveron LLC...
BioCentury | Aug 30, 2018
Company News

Management tracks: Lilly, Kiadis

...Robert Gagnon as CFO. He was CFO at Harvard Bioscience Inc. (NASDAQ:HBIO). Aging-related disease company Longeveron LLC...
...patient engagement platform CheckedUp (New York, N.Y.). BC Staff Akebia Therapeutics Inc. Harvard Bioscience Inc. Keryx Biopharmaceuticals Inc. Kiadis Pharma N.V. Longeveron...
Items per page:
1 - 2 of 2
BioCentury | Jan 20, 2021
Finance

IPO queue bulges further as Adagene, NexImmune are among latest to file

...largest shareholder.Filing for smaller offerings this week were two companies developing therapies for aging disorders: Longeveron LLC...
BioCentury | Aug 30, 2018
Company News

Management tracks: Lilly, Kiadis

...Robert Gagnon as CFO. He was CFO at Harvard Bioscience Inc. (NASDAQ:HBIO). Aging-related disease company Longeveron LLC...
...patient engagement platform CheckedUp (New York, N.Y.). BC Staff Akebia Therapeutics Inc. Harvard Bioscience Inc. Keryx Biopharmaceuticals Inc. Kiadis Pharma N.V. Longeveron...
Items per page:
1 - 2 of 2